BioCardia, Inc.
BCDA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000925741
In the last 90 days, BioCardia, Inc. insiders filed 9 open-market purchases and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in BioCardia, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- +1 vs. Q3 2021
- Shares held
- 2.98M
- +111.3K (+3.9%) vs. Q3 2021
- Total value
- $5.78M
- −$3.23M (−35.9%) vs. Q3 2021
- New holders
- 4
- 6 more added
- Sold out
- 3
- 2 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCDA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $1.65M |
| Q1 2026 | 18 | $831.1K |
| Q4 2025 | 20 | $812.3K |
| Q3 2025 | 18 | $551.9K |
| Q2 2025 | 16 | $593.2K |
| Q1 2025 | 12 | $623.8K |
| Q4 2024 | 13 | $272.2K |
| Q3 2024 | 9 | $316.6K |
| Q2 2024 | 10 | $227.8K |
| Q1 2024 | 22 | $790.8K |
| Q4 2023 | 24 | $1.37M |
| Q3 2023 | 16 | $709.6K |
| Q2 2023 | 23 | $4.43M |
| Q1 2023 | 23 | $4.09M |
| Q4 2022 | 25 | $4.87M |
| Q3 2022 | 23 | $3.17M |
| Q2 2022 | 26 | $3.10M |
| Q1 2022 | 24 | $5.49M |
| Q4 2021 | 23 | $5.78M |
| Q3 2021 | 22 | $9.01M |
| Q2 2021 | 20 | $12.3M |
| Q1 2021 | 19 | $13.5M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding BioCardia, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 69 | $0 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 983 | $2.00K | 0.00% | −400−28.9% | Reduced |
| Tower Research Capital LLC (TRC) | 2,200 | $4.00K | 0.00% | +2,200 | New |
| UBS Group AG | 5,813 | $11.0K | 0.00% | +5,813 | New |
| Bank of America Corp | 6,542 | $13.0K | 0.00% | +183+2.9% | Added |
| Simplex Trading, LLC | 10,749 | $20.0K | 0.00% | +6,378+145.9% | Added |
| Bank of New York Mellon Corp | 12,854 | $25.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 19,226 | $37.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 21,000 | $41.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 21,196 | $41.0K | 0.01% | +21,196 | New |
| Brown Advisory Inc | 33,085 | $64.0K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 34,488 | $67.0K | 0.00% | −4,769−12.1% | Reduced |
| BlackRock Inc. | 36,114 | $70.0K | 0.00% | +935+2.7% | Added |
| Commonwealth Equity Services, LLC | 42,307 | $82.0K | 0.00% | +25,815+156.5% | Added |
| Citadel Advisors LLC | 51,976 | $101.0K | 0.00% | +32,692+169.5% | Added |
| Virtu Financial LLC | 56,419 | $109.0K | 0.01% | +56,419 | New |
| Susquehanna International Group, LLP | 65,791 | $128.0K | 0.00% | +21,994+50.2% | Added |
| Geode Capital Management, LLC | 76,825 | $149.0K | 0.00% | 00.0% | Unchanged |
| Family Management Corp | 142,186 | $276.0K | 0.07% | 00.0% | Unchanged |
| CM Management, LLC | 329,000 | $638.0K | 0.48% | 00.0% | Unchanged |
| Vanguard Group Inc | 411,969 | $799.0K | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 660,637 | $1.28M | 0.01% | 00.0% | Unchanged |
| Roumell Asset Management, LLC | 938,380 | $1.82M | 2.43% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −43,549−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −10,015−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −3,612−100.0% | Sold out |